Irregular Cycles
Cycles becoming unpredictably shorter, longer, or erratic — the first clinically measurable sign of perimenopause.
Biological Mechanism
The STRAW+10 framework's primary diagnostic criteria for perimenopause are cycle-based, not hormonal, specifically because FSH fluctuates so dramatically during the transition that a single test can be misleading. Stage -2 (Early Transition) is defined by a persistent difference of 7 or more days in cycle length. This variability reflects irregular ovulation — when the follicle doesn't mature normally or ovulation fails altogether (anovulatory cycles), the luteal phase and thus cycle length become unpredictable. Without ovulation, progesterone is not produced, amplifying the progesterone deficiency of early perimenopause.
Common Misdiagnoses
Thyroid dysfunction (common coexisting condition — always check TSH), Polycystic ovarian syndrome (PCOS), Stress-related cycle disruption, Hyperprolactinaemia, Endometrial pathology (if accompanied by heavy bleeding)
Evidence-Based Treatments
- 01Cycle tracking
Three months of tracked cycles enables the 7-day variability criterion to be documented. Use Periwell to generate a chart you can show your provider.
- 02Progesterone support in luteal phase
For women with short luteal phases, irregular cycles, or worsening luteal symptoms (PMS), progesterone supplementation can regulate shedding and reduce symptoms.
- 03Combined HRT if other symptoms present
If cycle changes are accompanied by mood, cognitive, vasomotor, or sleep symptoms, sequential combined HRT addresses the full picture.